14 May 2024 | 03:00 PM GMT

Lessons in Therapy: What Diabetes Can Teach Other Chronic Diseases

Participants:

Suzanne Clough Chief Medical OfficerAmalgamRx
Suzanne Clough
Chief Medical OfficerAmalgamRx
Jochen Hurlebaus President & OwnerAluna Healthcare Consulting GmbH
Jochen Hurlebaus
President & OwnerAluna Healthcare Consulting GmbH
Arun Bhatia Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
Arun Bhatia
Commercial Strategy Lead - Digital HealthAstellas Pharma Rx+ Business Accelerator
BS
Bharath Sudharsan Chief Data Scientist & Head of AIAmalgamRx
BS
Bharath Sudharsan
Chief Data Scientist & Head of AIAmalgamRx
CR
Carolina Rebecchi OtherHealthAnea
CR
Carolina Rebecchi
OtherHealthAnea
Carolina Rebecchi Health Product ManagerHealthanea
Carolina Rebecchi
Health Product ManagerHealthanea
Ekaterina Karpusova EMEA BO & InnovationBAYER
Ekaterina Karpusova
EMEA BO & InnovationBAYER
Jenny Ostroth Manager, Digital StrategyDigital Foundry
Jenny Ostroth
Manager, Digital StrategyDigital Foundry
Paul Upham Global Head of Smart DevicesRoche / Genentech
Paul Upham
Global Head of Smart DevicesRoche / Genentech
RK
Ryan Kosiba Lead Data ScientistAmalgam Rx
RK
Ryan Kosiba
Lead Data ScientistAmalgam Rx
Tanja Dowe Managing DirectorAngelini Ventures
Tanja Dowe
Managing DirectorAngelini Ventures
Tom Crohan Senior Director, Partnerships & Business DevGoMo Health
Tom Crohan
Senior Director, Partnerships & Business DevGoMo Health
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

As digital health continues its transformative journey, the experiences gained in diabetes management can serve as a guiding light for broader applications. Continuous glucose monitoring (CGM) devices, coupled with mobile apps, facilitate real-time tracking of blood glucose levels, promoting a proactive approach to diabetes care. This feedback loop can serve as a potential model for other chronic diseases, encouraging the creation of similar technologies empowering individuals in continuous health monitoring.

Moreover, the integration of artificial intelligence (AI) and machine learning in diabetes digital health highlights the potential for personalised interventions. By analysing extensive data, these technologies offer tailored recommendations based on lifestyle patterns, dietary habits, and physiological responses. This success in personalisation could inspire analogous strategies for managing various chronic diseases, fostering more effective and individualised care plans that account for each patient's unique characteristics.

Join the conversation to explore:

  • What advantages of continuous monitoring in diabetes could be adapted for other chronic conditions?
  • How might AI and machine learning personalise interventions for chronic diseases, drawing from successes in diabetes management?
  • How can collaborative dynamics in digital health ecosystems for diabetes inspire integrated solutions for managing various chronic diseases?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.